Table of Contents
1. Introduction
1.1. Introduction
1.2. Market
Scope
1.2.1 Market Definition
1.2.2 Segments Covered
1.2.3 Regional Segmentation
1.3. Research
Timeframe
1.4. Currency
Considered
1.5. Study
Limitations
1.6. Stakeholders
1.7. List
of Abbreviations
1.8. Key
Conferences and Events (2026-2027)
2. Research Methodology
2.1. Secondary
Research
2.2. Primary
Research
2.3. Market
Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4. Market
Forecasting
3. Executive
Summary
3.1. AI In Ophthalmology Market Snapshot
(2026-2031)
3.2. Segment
Overview
3.3. Regional
Snapshot
3.4. Competitive Insights
4. Market
Overview
4.1. Market
Dynamics
4.1.1. Drivers
4.1.1.1. Rising global prevalence of
diabetic retinopathy and blindness cases
4.1.1.2. Shortage of trained
ophthalmologists in rural and remote regions
4.1.1.3. Growing geriatric population
prone to age-related eye disorders
4.1.1.4. Expanding adoption of
automated retinal fundus screening tools
4.1.1.5. Expanding use of optical
coherence tomography with AI analytics
4.1.2.
Restraints
4.1.2.1. Limited clinical validation
across diverse patient populations
4.1.2.2. Interoperability challenges
between AI tools and legacy hospital systems
4.1.2.3. High cost of AI-enabled
diagnostic equipment and software
4.1.3. Opportunities
4.1.3.1. Expansion of AI-driven triage
systems for urgent case prioritization
4.1.3.2. Expansion into rare and
underdiagnosed eye disorder detection
4.1.3.3. Untapped potential in
emerging economies
4.1.3.4. Increasing scope for
multilingual, region-specific diagnostic applications
4.2. Key
Market Trends
4.2.1. Increasing adoption of deep
learning for retinal image analysis
4.2.2. Growing integration of AI
with optical coherence tomography scans
4.3. Unmet
Market Needs
4.4. Industry Speaks
5. Global AI
in Ophthalmology Market Size & Forecast (2024-2031),
By Technology, USD Billion
5.1. Introduction
5.2. Machine
Learning
5.3. Deep
Learning and Neural Networks
5.4. Natural
Language Processing
5.5. Computer
Vision
5.6. Other Technologies
6. Global AI
in Ophthalmology Market Size & Forecast (2024-2031),
By Application, USD Billion
6.1. Introduction
6.2. Disease
Detection and Monitoring
6.2.1. Retinal
Disease Detection
6.2.2. Glaucoma
Detection & Monitoring
6.3. Surgical
Planning and Outcome Prediction
6.4. Workflow
automation for ophthalmic imaging
6.5. Other Applications
7. Global AI
in Ophthalmology Market Size & Forecast (2024-2031),
By Deployment Mode, USD Billion
7.1. Introduction
7.2. On Premise
7.3. Cloud-based
8. Global AI
in Ophthalmology Market Size & Forecast (2024-2031),
By End User, USD Billion
8.1. Introduction
8.2. Hospitals
8.3. Specialty
Ophthalmology Clinics
8.4. Academic
& Research Institutions
8.5. Payers
& Insurance Companies
8.6. Other End Users
9. Global AI
in Ophthalmology Market Size & Forecast (2024-2031),
By Region, USD Billion
9.1. Introduction
9.2. North
America AI in Ophthalmology Market Size & Forecast (2024-2031), By Country,
USD Billion
9.2.1. US
9.2.1.1. Market Size & Forecast, By Technology (USD Billion)
9.2.1.2.
Market Size
& Forecast, By Application (USD Billion)
9.2.1.3.
Market Size
& Forecast, By Deployment Mode (USD Billion)
9.2.1.4.
Market Size
& Forecast, By End User (USD Billion)
9.2.2. Canada
9.2.2.1. Market Size
& Forecast, By Technology (USD Billion)
9.2.2.2.
Market Size
& Forecast, By Application (USD Billion)
9.2.2.3.
Market Size
& Forecast, By Deployment Mode (USD Billion)
9.2.2.4.
Market Size
& Forecast, By End User (USD Billion)
9.3. Europe
AI in Ophthalmology Market
Size & Forecast (2024-2031), By Country, USD Billion
9.3.1. UK
9.3.1.1. Market Size
& Forecast, By Technology (USD Billion)
9.3.1.2.
Market Size
& Forecast, By Application (USD Billion)
9.3.1.3.
Market Size
& Forecast, By Deployment Mode (USD Billion)
9.3.1.4.
Market Size
& Forecast, By End User (USD Billion)
9.3.2. Germany
9.3.2.1. Market Size
& Forecast, By Technology (USD Billion)
9.3.2.2.
Market Size
& Forecast, By Application (USD Billion)
9.3.2.3.
Market Size
& Forecast, By Deployment Mode (USD Billion)
9.3.2.4.
Market Size
& Forecast, By End User (USD Billion))
9.3.3. France
9.3.3.1. Market Size
& Forecast, By Technology (USD Billion)
9.3.3.2.
Market Size
& Forecast, By Application (USD Billion)
9.3.3.3.
Market Size
& Forecast, By Deployment Mode (USD Billion)
9.3.3.4.
Market Size
& Forecast, By End User (USD Billion)
9.3.4. Italy
9.3.4.1. Market Size
& Forecast, By Technology (USD Billion)
9.3.4.2.
Market Size
& Forecast, By Application (USD Billion)
9.3.4.3.
Market Size
& Forecast, By Deployment Mode (USD Billion)
9.3.4.4.
Market Size
& Forecast, By End User (USD Billion)
9.3.5. Spain
9.3.5.1. Market Size
& Forecast, By Technology (USD Billion)
9.3.5.2.
Market Size
& Forecast, By Application (USD Billion)
9.3.5.3.
Market Size
& Forecast, By Deployment Mode (USD Billion)
9.3.5.4.
Market Size
& Forecast, By End User (USD Billion)
9.3.6. Rest
of Europe
9.3.6.1. Market Size
& Forecast, By Technology (USD Billion)
9.3.6.2.
Market Size
& Forecast, By Application (USD Billion)
9.3.6.3.
Market Size
& Forecast, By Deployment Mode (USD Billion)
9.3.6.4.
Market Size
& Forecast, By End User (USD Billion)
9.4. Asia
Pacific (APAC) AI in Ophthalmology Market Size & Forecast (2024-2031),
By Country, USD Billion
9.4.1. China
9.4.1.1. Market Size
& Forecast, By Technology (USD Billion)
9.4.1.2.
Market Size
& Forecast, By Application (USD Billion)
9.4.1.3.
Market Size
& Forecast, By Deployment Mode (USD Billion)
9.4.1.4.
Market Size
& Forecast, By End User (USD Billion)
9.4.2. Japan
9.4.2.1. Market Size
& Forecast, By Technology (USD Billion)
9.4.2.2.
Market Size
& Forecast, By Application (USD Billion)
9.4.2.3.
Market Size
& Forecast, By Deployment Mode (USD Billion)
9.4.2.4.
Market Size
& Forecast, By End User (USD Billion)
9.4.3. India
9.4.3.1. Market Size
& Forecast, By Technology (USD Billion)
9.4.3.2.
Market Size
& Forecast, By Application (USD Billion)
9.4.3.3.
Market Size
& Forecast, By Deployment Mode (USD Billion)
9.4.3.4.
Market Size
& Forecast, By End User (USD Billion)
9.4.4. Rest
of Asia Pacific
9.4.4.1. Market Size
& Forecast, By Technology (USD Billion)
9.4.4.2.
Market Size
& Forecast, By Application (USD Billion)
9.4.4.3.
Market Size
& Forecast, By Deployment Mode (USD Billion)
9.4.4.4.
Market Size
& Forecast, By End User (USD Billion)
9.5. Latin
America (LATAM) AI in Ophthalmology Market Size & Forecast (2024-2031),
USD Billion
9.5.1. Market Size
& Forecast, By Technology (USD Billion)
9.5.2.
Market Size
& Forecast, By Application (USD Billion)
9.5.3. Market Size & Forecast, By
Deployment Mode (USD Billion)
9.5.4.
Market Size
& Forecast, By End User (USD Billion)
9.6. Middle
East & Africa (MEA) AI in Ophthalmology Market Size & Forecast (2024-2031),
USD Billion
9.6.1. Market Size
& Forecast, By Technology (USD Billion)
9.6.2.
Market Size
& Forecast, By Application (USD Billion)
9.6.3. Market Size & Forecast, By
Deployment Mode (USD Billion)
9.6.4. Market Size & Forecast, By End User (USD Billion)
10. Competitive
Landscape
10.1. Key Players and their Competitive Positioning
10.1.1. Key
Player Comparison
10.1.2. Segment-wise
Player Mapping
10.1.3. Market
Share Analysis (2025)
10.1.4. Company
Categorization Matrix
10.1.4.1. Dominants/Leaders
10.1.4.2. New
Entrants
10.1.4.3. Emerging
Players
10.1.4.4. Innovative
Players
10.2. Key Strategies Assessment, By Player (2023-2026)
10.2.1. New
Product Launch
10.2.2. Partnerships,
Agreements, & Collaborations
10.2.3. Mergers
& Acquisitions
10.2.4. Geographic Expansion
11.
Company
Profiles*
(Business Overview, Financial
Performance**, Products Offered, Recent Developments)
11.1. OphtAI
11.2. Eyenuk, Inc.
11.3. IBM Corporation
11.4. Optos plc
11.5. Zeiss
11.6. Topcon Healthcare
11.7. Nidek Co. Ltd.
11.8. Altris AI
11.9. Oculus Maxima Limited
11.10. Siemens Healthineers
11.11. Other Prominent Players
Note: *Indicative list
**For listed companies